AEterna Zentaris Inc.  

(Public, TSE:AEZ)   Watch this stock  
Find more results for AEZ
1.57
-0.04 (-2.48%)
Sep 2 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.50 - 1.68
52 week 1.04 - 1.81
Open 1.64
Vol / Avg. 115,280.00/12,745.00
Mkt cap 90.97M
P/E     -
Div/yield     -
EPS -0.98
Shares 57.89M
Beta 0.82
Inst. own     -
Sep 9, 2014
AEterna Zentaris Inc at Rodman & Renshaw Global Investment Conference - 3:20PM EDT - Add to calendar
Aug 13, 2014
AEterna Zentaris Inc at Canaccord Genuity Growth Conference
Jun 18, 2014
AEterna Zentaris Inc at Bloom Burton & Co Healthcare Investor Conference
  

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin - -441.13%
Operating margin - -444.96%
EBITD margin - -411.89%
Return on average assets -28.57% -42.94%
Return on average equity -103.09% -525.41%
Employees 76 -
CDP Score - -

Address

1405 du Parc-Technologique Blvd.
QUEBEC, QC G1P 4P5
Canada
+1-418-6528525 (Phone)
+1-418-9489191 (Fax)

Website links

Description

Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrine therapy. The Company�s pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. The development priorities in oncology are the completion of Phase 3 trials with perifosine in colorectal cancer (CRC) and in multiple myeloma (MM), as well as the further advancement of AEZS-108, for which it has completed a Phase 2 trial in advanced endometrial and advanced ovarian cancer. Its pipeline also encompasses other earlier-stage programs in oncology. AEZS-112, which is an oral anticancer agent, which includes three mechanisms of action (tubulin, topoisomerase II and angiogenesis inhibition) has completed a Phase 1 trial in advanced solid tumors and lymphoma.

Officers and directors

David A. Dodd Chairman of the Board, President, Chief Executive Officer
Age: 64
Dennis Turpin CA Chief Financial Officer, Senior Vice President
Richard Sachse M.D., Ph.D. Senior Vice President, Chief Scientific Officer, Chief Medical Officer
Jude Dinges Chief Commercial Officer, Senior Vice President
Elliot Shapiro Corporate Secretary
Amelie Metivier Assistant Secretary
Juergen H. L. Ernst Lead Director
Age: 75
M. Marcel Aubut QC Independent Director
Jose P. Dorais Independent Director
Carolyn Egbert Independent Director